Suffering from prostate cancer or benign prostatic hyperplasia (BPH) is not the end of a relationship. Technology and ...
Frequent urination, urgency and waking up at night to urinate are often blamed on an enlarged prostate. However, doctors say ...
OXFORD, UK / ACCESS Newswire / June 15, 2026 /Fine Treatment has highlighted increasing interest in non-invasive therapeutic ...
(NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today ...
Researchers at The University of Texas MD Anderson Cancer Center have identified FOXA1 as a potentially sensitive marker for ...
The Prostatic Urethral Lift (PUL) procedure is a minimally invasive option for lower urinary tract symptoms (LUTS) in patients with bladder outlet obstruction (BOO) that provides significant and rapid ...
The purpose of this narrative review is to evaluate the role of prostatic inflammation as a treatment target for lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO) and ...
THE acid phosphatase content of malignant prostatic tissue is regarded as an example of the retention by the neoplastic growth of a biochemical characteristic of the fully differentiated tissue of ...
Despite its importance, the prostate gland in an adult man is only about the size and shape of a walnut and weighs less than 1 ounce (20 to 30 grams). It is located below the bladder, above the pelvic ...
For men with benign prostatic hyperplasia (BPH), prostatic artery embolization (PAE) is safe and effective over 24 months of follow-up, according to a study published online Sept. 4 in Cardiovascular ...
JW Pharmaceutical and JW Shinyak Hold Symposium on Benign Prostatic Hyperplasia Treatment "Truepass"
JW Pharmaceutical and JW Shinyak announced on the 10th that they held the "J STAR Symposium" at the Grand Walkerhill Seoul ...
Contemporary diagnosis of very low risk prostate cancer in a multi-centered hospital system. Use of the Prostatype P-score to predict adverse pathology (AP) at radical prostatectomy (RP). This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results